F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Adalimumab

Page 1 of 1 ( 31 items )
<<
1
>>

1	Three-year outcomes of tumor necrosis factor alpha inhibitor therapy in rheumatoid arthritis patients with elevated liver enzymes 7/25/2025 12:09:40 PM \| Browse: 71 \| Download: 379
2	Evaluation of biological therapies in autoimmune hepatitis: A case-based systematic review 3/18/2025 4:25:39 AM \| Browse: 124 \| Download: 517
3	Real-world experience and long-term outcomes of a mandatory non-medical switch of adalimumab originator to biosimilars in inflammatory bowel disease 11/21/2024 7:04:50 AM \| Browse: 177 \| Download: 868
4	Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis 2/25/2024 3:12:20 PM \| Browse: 283 \| Download: 1177
5	Dose escalation of adalimumab as a strategy to overcome anti-drug antibodies: A case report of infantile-onset inflammatory bowel disease 10/12/2023 10:39:02 AM \| Browse: 239 \| Download: 865
6	Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology 7/27/2023 1:26:07 AM \| Browse: 212 \| Download: 883
7	Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease 5/11/2023 8:05:04 AM \| Browse: 311 \| Download: 915
8	Tislelizumab-related enteritis successfully treated with adalimumab: A case report 9/27/2022 1:00:17 PM \| Browse: 366 \| Download: 1243
9	Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study 9/7/2022 8:29:04 AM \| Browse: 742 \| Download: 2290
10	Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis 6/17/2022 3:19:26 AM \| Browse: 644 \| Download: 1971
11	Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients 5/13/2022 8:46:12 AM \| Browse: 595 \| Download: 1630
12	Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study 3/3/2022 6:59:41 AM \| Browse: 820 \| Download: 2748
13	Predictive value of biologic blood concentration on endoscopic inactivity in inflammatory bowel disease: A systematic review 3/3/2021 10:02:01 AM \| Browse: 835 \| Download: 2294
14	First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus 11/20/2020 4:04:17 AM \| Browse: 1037 \| Download: 2486
15	Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy 9/14/2017 3:13:08 AM \| Browse: 1195 \| Download: 1741
16	Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature 8/1/2017 12:23:47 AM \| Browse: 1348 \| Download: 2219
17	Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study 6/14/2017 9:25:57 AM \| Browse: 1361 \| Download: 2706
18	Combination therapy for inflammatory bowel disease 5/4/2017 8:16:34 AM \| Browse: 1388 \| Download: 2131
19	Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies 1/5/2017 11:10:00 AM \| Browse: 1141 \| Download: 2295
20	Adalimumab and pharmacokinetics: Impact on the clinical prescription for inflammatory bowel disease 3/4/2016 3:35:00 PM \| Browse: 1292 \| Download: 2183
21	Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases 6/29/2015 4:40:00 PM \| Browse: 1440 \| Download: 2705
22	Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody 6/11/2015 10:11:00 AM \| Browse: 1313 \| Download: 1875
23	Adalimumab-induced interstitial pneumonia in a patient with Crohn’s disease 2/11/2015 4:38:00 PM \| Browse: 1270 \| Download: 1897
24	Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review 9/16/2014 11:44:00 AM \| Browse: 1257 \| Download: 1006
25	Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients 9/16/2014 11:44:00 AM \| Browse: 1323 \| Download: 1713
26	Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease 9/16/2014 9:54:00 AM \| Browse: 1390 \| Download: 1339
27	Intestinal Behçet’s disease appearing during treatment with adalimumab in a patient with ankylosing spondylitis 9/15/2014 8:53:00 PM \| Browse: 1187 \| Download: 1488
28	Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review 9/11/2014 8:40:00 PM \| Browse: 1508 \| Download: 1342
29	Severe cholestasis due to adalimumab in a Crohn’s disease patient 9/10/2014 5:06:00 PM \| Browse: 1411 \| Download: 1384
30	Therapeutic drug monitoring in patients with inflammatory bowel disease 8/29/2014 5:07:00 PM \| Browse: 1357 \| Download: 1571
31	TNF inhibitors to treat ulcerative colitis in a metastatic breast cancer patient: A case report and literature review 8/27/2014 5:15:00 PM \| Browse: 1075 \| Download: 1087

Page 1 of 1 ( 31 items )
<<
1
>>

1	Three-year outcomes of tumor necrosis factor alpha inhibitor therapy in rheumatoid arthritis patients with elevated liver enzymes 7/25/2025 12:09:40 PM \| Browse: 71 \| Download: 379
2	Evaluation of biological therapies in autoimmune hepatitis: A case-based systematic review 3/18/2025 4:25:39 AM \| Browse: 124 \| Download: 517
3	Real-world experience and long-term outcomes of a mandatory non-medical switch of adalimumab originator to biosimilars in inflammatory bowel disease 11/21/2024 7:04:50 AM \| Browse: 177 \| Download: 868
4	Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis 2/25/2024 3:12:20 PM \| Browse: 283 \| Download: 1177
5	Dose escalation of adalimumab as a strategy to overcome anti-drug antibodies: A case report of infantile-onset inflammatory bowel disease 10/12/2023 10:39:02 AM \| Browse: 239 \| Download: 865
6	Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology 7/27/2023 1:26:07 AM \| Browse: 212 \| Download: 883
7	Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease 5/11/2023 8:05:04 AM \| Browse: 311 \| Download: 915
8	Tislelizumab-related enteritis successfully treated with adalimumab: A case report 9/27/2022 1:00:17 PM \| Browse: 366 \| Download: 1243
9	Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study 9/7/2022 8:29:04 AM \| Browse: 742 \| Download: 2290
10	Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis 6/17/2022 3:19:26 AM \| Browse: 644 \| Download: 1971
11	Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients 5/13/2022 8:46:12 AM \| Browse: 595 \| Download: 1630
12	Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study 3/3/2022 6:59:41 AM \| Browse: 820 \| Download: 2748
13	Predictive value of biologic blood concentration on endoscopic inactivity in inflammatory bowel disease: A systematic review 3/3/2021 10:02:01 AM \| Browse: 835 \| Download: 2294
14	First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus 11/20/2020 4:04:17 AM \| Browse: 1037 \| Download: 2486
15	Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy 9/14/2017 3:13:08 AM \| Browse: 1195 \| Download: 1741
16	Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature 8/1/2017 12:23:47 AM \| Browse: 1348 \| Download: 2219
17	Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study 6/14/2017 9:25:57 AM \| Browse: 1361 \| Download: 2706
18	Combination therapy for inflammatory bowel disease 5/4/2017 8:16:34 AM \| Browse: 1388 \| Download: 2131
19	Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies 1/5/2017 11:10:00 AM \| Browse: 1141 \| Download: 2295
20	Adalimumab and pharmacokinetics: Impact on the clinical prescription for inflammatory bowel disease 3/4/2016 3:35:00 PM \| Browse: 1292 \| Download: 2183
21	Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases 6/29/2015 4:40:00 PM \| Browse: 1440 \| Download: 2705
22	Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody 6/11/2015 10:11:00 AM \| Browse: 1313 \| Download: 1875
23	Adalimumab-induced interstitial pneumonia in a patient with Crohn’s disease 2/11/2015 4:38:00 PM \| Browse: 1270 \| Download: 1897
24	Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review 9/16/2014 11:44:00 AM \| Browse: 1257 \| Download: 1006
25	Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients 9/16/2014 11:44:00 AM \| Browse: 1323 \| Download: 1713
26	Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease 9/16/2014 9:54:00 AM \| Browse: 1390 \| Download: 1339
27	Intestinal Behçet’s disease appearing during treatment with adalimumab in a patient with ankylosing spondylitis 9/15/2014 8:53:00 PM \| Browse: 1187 \| Download: 1488
28	Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review 9/11/2014 8:40:00 PM \| Browse: 1508 \| Download: 1342
29	Severe cholestasis due to adalimumab in a Crohn’s disease patient 9/10/2014 5:06:00 PM \| Browse: 1411 \| Download: 1384
30	Therapeutic drug monitoring in patients with inflammatory bowel disease 8/29/2014 5:07:00 PM \| Browse: 1357 \| Download: 1571
31	TNF inhibitors to treat ulcerative colitis in a metastatic breast cancer patient: A case report and literature review 8/27/2014 5:15:00 PM \| Browse: 1075 \| Download: 1087